IP
IndiaPulse

COROMANDEL

Mid Cap

Coromandel International Limited

Industrials

Coromandel International Limited is an Indian agri-input company, primarily engaged in the manufacturing and marketing of fertilizers (Nutrients segment) and crop protection chemicals (CPC segment). It also offers specialty nutrients and organic fertilizers, serving the agricultural sector across India.

₹1,815.5
+64.40 · +3.68%
Quote09 Jun, 10:02 am
Fundamentals08 Jun 2026 · screener
Score08 Jun, 11:00 pm · v4.2-nightly
Tags02 May 2026
Data confidence
Fresh enough for analysis
Investor decision lenses

One read, four checks

75+ is strong, 60-74 is usable, 45-59 is mixed, and below 45 needs caution. These are research lenses, not buy/sell instructions.

Mixed fundamentals, management trust is supportive, price trend is neutral, and recent execution is mixed.

Suggested next step
Research, do not rush
The four lenses are not strongly aligned. Compare peers and wait for a cleaner setup.
U-Score
FAIR VALUE
46

Fundamental lens: valuation, quality, growth, balance sheet, and cash flow.

Trust
Healthy Trust
77

low confidence · 0/0 claims checked

Technical
Neutral
45

Timing lens: price trend and sector relative strength.

Result consistency
stable
68

Rolling lens: recent quarterly delivery, not the latest single-result score.

Latest result

Quarter ended 31 Mar 2026

Bad · 0/100

PAT -80% YoY · margin compression · Rev +20% YoY

Filed 07 May 2026
Open results browser →
MetricThis quarterYoYQoQ
Revenue₹6,004 Cr+20.4%-31.6%
EBITDA₹488 Cr+19.3%-39.0%
Operating margin8.0%+0 bps-100 bps
PAT₹115 Cr-80.1%-76.4%
PAT margin1.9%-967 bps-364 bps

NDF means not disclosed in the current structured filing feed. It is intentionally not treated as zero.

Business and thesis

Where growth can come from, and what can break the case

Thesis under stressReviewed 2026-06-03T19:11:30.607Z
Management commentary snapshot

Q4 FY26 consolidated revenue grew 20% YoY to ₹6,004 Cr, but PAT plunged 80% YoY to ₹115 Cr due to a sharp decline in Nutrients segment PBIT and exceptional items. Full-year FY26 revenue rose 31% YoY to ₹31,480 Cr, while PAT declined 8% YoY to ₹1,898 Cr.

While full-year revenue growth was strong, the significant Q4 PAT decline and overall margin contraction (EBITDA and PAT) raise concerns. The Nutrients segment's Q4 PBIT drop is a key issue, partially offset by strong performance in the CPC segment, boosted by an acquisition. Exceptional items also impacted Q4.

Growth engines

CPC Segment Growth

Consolidated CPC revenue grew 50% YoY in FY26 and 54% YoY in Q4 FY26, with PBIT up 41% and 19% respectively.

Urea Sales Volume

Urea sales volume increased 66.6% YoY in FY26 and 42.8% YoY in Q4 FY26 for the Nutrients segment.

Imported NPK+DAP Sales Volume

Imported NPK+DAP sales volume grew 54.8% YoY in FY26 and 26.1% YoY in Q4 FY26.

Capacity and execution

NACL Industries Acquisition

NACL Industries Limited became a subsidiary of Coromandel effective August 8, 2025, contributing to consolidated CPC segment growth.

Headwinds

Exceptional Items

The company reported -₹71 Cr in exceptional items in Q4 FY26 and FY26, impacting PAT.

Nutrients Segment PBIT Decline (Q4)

Nutrients segment PBIT declined 18% YoY in Q4 FY26, despite a 15% increase in sales.

Overall Margin Contraction

Consolidated EBITDA margin decreased from 9% to 8% in Q4 FY26 and from 11% to 10% in FY26. PAT margin also declined.

Management accountability

What management said, and what results must prove

Issuer guidance and extracted claims are tracked against later reported outcomes. Treat these as management statements, not IndiaPulse forecasts.

Analyst reading lens
Compare BOTH

Both quarterly (Q4) and annual (FY) comparisons are essential. Q4 shows recent momentum and specific challenges (e.g., Nutrients PBIT drop, exceptional items), while FY provides a broader view of annual performance and strategic impact (e.g., NACL acquisition).

Sector KPIs management disclosed

Revenue from Operations (Consolidated)

Q4 FY26: ₹6,004 Cr (+20% YoY); FY26: ₹31,480 Cr (+31% YoY).

EBITDA (Consolidated)

Q4 FY26: ₹494 Cr (+16% YoY); FY26: ₹3,232 Cr (+23% YoY).

PAT (Consolidated)

Q4 FY26: ₹115 Cr (-80% YoY); FY26: ₹1,898 Cr (-8% YoY).

EBITDA Margin (Consolidated)

Q4 FY26: 8% (vs 9% Q4 FY25); FY26: 10% (vs 11% FY25).

Thesis monitor

Numbers and claims to verify in the next filings

CheckpointCurrent evidenceWhat to verify next
Nutrients Segment PBIT TrendQ4 FY26 PBIT down 18% YoY.Reversal of PBIT decline and margin improvement in the Nutrients segment.
Consolidated Margin TrendFY26 EBITDA margin 10% (vs 11% FY25), PAT margin 6% (vs 9% FY25).Stabilization and expansion of consolidated EBITDA and PAT margins.
Integration of NACL IndustriesNACL became a subsidiary in August 2025, boosting CPC segment.Continued strong performance and synergy realization from the acquired entity.

Verification checkpoints are IndiaPulse research interpretation, not investment advice.

Technical timing lens

Trend score and candlestick chart

45Neutral

SMA20 -15.7% / mo · near 52W low

Stock trend: 41
Sector RS: 51
Sector 3M: +0.4% vs Nifty +0.1%

Technical chart

COROMANDELdaily · 1Y-17.0%
Latest close ₹1807.10 on 2026-06-09
Bar
+3.2%
RSI
45
MACD hist
2.92
52W pos
13%
Hover for OHLC, volume, and indicators. Use range buttons above the chart to zoom.
₹1.7k₹1.9k₹2.1k₹2.3k₹2.5k52H52L2025-122026-03Vol2025-112026-012026-022026-042026-06
Up bar
Down bar
Volume
Result date
SMA 50
RSI(14)

Technical trend read

Mixed signals

Signals are conflicting — long-term trend unclear. RSI 45. Wait for confirmation.

  • SMA20 falling (~10.2% over last month) — short-term momentum negative.
  • RSI(14) at 45 — rising, no extreme reading.
  • MACD above signal but histogram contracting — bullish momentum cooling.
  • 28% off 52W high · 6% above 52W low.

Mechanical read from the price + indicator series above. Not a recommendation — technical setups can reverse without warning, especially around earnings and macro events.

Deep research

Valuation, score drivers, trust methodology, financials, and peers

Use these sections after reviewing the decision summary, latest result, thesis, management accountability, and technical timing above.

46U-SCORE
Financial Turnaround

Fundamental score breakdown

FAIR VALUE
Valuation5/30
Growth9/25
Quality12/20
Balance Sheet10/15
Cash Flow4/10
Piotroski
8/9 (+5)
Penalties
1
Raw sum
46

Why this score?

Top U-Score contributors and drags from the latest stored fundamentals.

46/100 · FAIR VALUE

Positive drivers

  • Piotroski is strong at 8/9.
  • Balance sheet contributes 10/15 to the score.
  • Quality contributes 12/20 to the score.

Main drags

  • Valuation is weaker at 5/30; verify the latest quarterly trend.
  • Growth is weaker at 9/25; verify the latest quarterly trend.
  • Cash flow is weaker at 4/10; verify the latest quarterly trend.
Sector valuation model

Cyclical valuation: normalized earnings, not just trailing PE

Cyclical companies can look cheapest near peak profits, so IndiaPulse flags value-trap risk separately.

Cyclical normalized
Primary lens
Mid-cycle PE/EV/EBITDA using multi-year average margins or earnings.
Secondary checks
Current margin versus 5-year average, balance sheet strength, commodity cycle.
Main risk check
A low trailing PE may mean peak-cycle earnings, not true cheapness.
PE
25.7
PB
4.1
EV/EBITDA
14.2
ROE
17.0%
ROCE
22.8%
FCF Yield
Debt/Equity
0.1
MoS
+9.6%
Cyclical/value-trap warning
This sector can look cheap when profits are temporarily high. Check mid-cycle margins/earnings before relying on trailing PE.
Score movement

Stored run vs live recompute

This shows the stored score trend when snapshots exist, and also compares the latest stored nightly score with a live recompute from current fundamentals and price.

Stored run: 08 Jun 2026
v4.2-nightly
Final score
46
Previous: 49 (-3)
Verdict
FAIR VALUE
Previous: FAIR VALUE
Margin of safety
+9.6%
Previous: +13.0%

Score history

12 stored score snapshots. Latest stored move: +1 points.

08 Jun 2026
v4.2-nightly
46
46
48
48
49
49
49
49
48
48
48
49

Factor attribution

Valuation
5-3
was 8
Trust Score
77Healthy Trust · low confidenceTrust Lite

Trust asks: does management behaviour match later outcomes? Higher is better, but confidence and evidence depth matter as much as the number.

Healthy Trust: Claim history is still being built. It ranks around the 85th percentile of the scored universe and 84th percentile within Industrials. No major sub-score weakness stands out.

High Trust Lite: Promoter holding is 56.4%. Key concern: 1 of the latest 4 quarters had PAT decline worse than 25% YoY.

Computed 08 Jun 2026
management-trust-v1
88 docs indexed · 60 concall links
Score band
Healthy Trust

Generally investable credibility. Look for weak sub-scores before increasing position size.

Relative rank
85th percentile

overall median 67 · Industrials: 84th pctile, median 68 · Mid: 59th pctile, median 76

Evidence depth
Financial-only

88 documents indexed, but claim history is not strong enough yet.

Claim delivery
Outcome history still building

0 claims extracted · No contradicted claim yet

How to read this Trust Score

Healthy Trust · low confidence
What it measures
Reliability of management and financial delivery, using financial behaviour only.
Confidence
Treat this as an early read until more concalls and outcomes are matched.
Investor use
Can support position sizing if valuation and trend also agree.

Read Trust alongside U-Score, result consistency, and technical trend. A cheap stock with weak Trust needs a larger margin of safety; a high Trust score does not make an expensive stock attractive by itself.

Forensic breakdown

Read low sub-scores as due-diligence warnings, not automatic sell signals.

Promoter
86
strong · holding, pledge, alignment
Cash flow
67
acceptable · profit to cash conversion
Balance sheet
89
strong · leverage and solvency
Discipline
74
acceptable · capital discipline
Results
68
acceptable · quarterly consistency

Trust positives

  • Promoter holding is 56.4%.
  • Promoter pledge is zero.
  • 6 years of positive FCF.
  • ROCE is 22.8%.

Trust risks

  • 1 of the latest 4 quarters had PAT decline worse than 25% YoY.

Trust Lite uses financial behaviour only. Prefer claim-tested Trust when enough concall claims have later outcomes.

Intrinsic value

Graham Number
₹797.23
-127.7% MoS
DCF Fair PE
30.3
DCF Fair Value
₹2,007.87
+9.6% MoS
PEG
2.86

Fundamentals

Valuation

P/E
25.70
P/B
4.11
EV/EBITDA
14.17
Market Cap
51631.00Cr

Profitability

ROE
17.00%
ROCE
22.80%
ROA
7.75%
Dividend Y
0.63%

Growth (CAGR)

Revenue 5Y
17.00%
EPS 5Y
9.00%
Revenue 3Y
2.00%
EPS 3Y
-1.06%

Balance Sheet

Debt/Equity
0.12
Interest Coverage
9.38×
Altman Z
5.21
Book Value
426.00

Cash Flow

FCF Yield
FCF Positive Y
6/5
OCF
1558.00 Cr
EPS TTM
66.31

Shareholding

Promoter Hold
56.35%
Promoter Pledge
0.00%
Momentum 52W
4%

Financial History

Updated 9/6/2026

Revenue

₹ Cr
No data

Net Profit

₹ Cr
No data

Return on Equity

%
No data
Verify on:NSE India ↗
All information is for study purposes only. For investment decisions, consult your financial advisor. See Playbook for methodology.